ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Physician Assistant

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,210Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 170

$282K Total Retail Price of All Prescriptions

Rank: 10 out of 170

237 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 237 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

11% of this provider’s 237 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 6,281 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
SERTRALINE HCL 269 241 1 21
GABAPENTIN 256 208 2 10
OMEPRAZOLE 226 221 3 5
POTASSIUM CHLORIDE 194 186 4 8
SIMVASTATIN 192 177 5 3
LEVOTHYROXINE SODIUM 188 149 6 2
LOSARTAN POTASSIUM 172 146 7 18
CARVEDILOL 165 165 8 35
FUROSEMIDE 162 152 9 6
HYDROCODONE-ACETAMINOPHEN 150 93 S3 10 1
AMLODIPINE BESYLATE 148 138 11 7
TRAZODONE HCL 142 111 12 77
DONEPEZIL HCL 141 141 13 40
METFORMIN HCL 126 114 14 9
RANITIDINE HCL 125 121 15 71
FLUTICASONE PROPIONATE 115 99 16 19
MELOXICAM 105 77 17 20
TRAMADOL HCL 103 100 18 12
METOCLOPRAMIDE HCL 96 91 19 108
MIRTAZAPINE 93 77 20 59
HYDROCHLOROTHIAZIDE 93 89 20 13
PRAVASTATIN SODIUM 92 74 22 17
TRIAMTERENE-HCTZ 91 77 23 75
TAMSULOSIN HCL 88 88 24 30
CYMBALTA 86 82 25 45
LISINOPRIL 83 74 26 4
PANTOPRAZOLE SODIUM 82 65 27 54
BENAZEPRIL HCL 78 74 28 70
METOPROLOL TARTRATE 72 72 29 14
DIGOXIN 71 71 30 58
CIPROFLOXACIN HCL 69 56 31 52
AZITHROMYCIN 68 55 32 24
PREDNISONE 66 60 33 37
ZOLPIDEM TARTRATE 65 49 34 22
GLIMEPIRIDE 65 54 34 93
WARFARIN SODIUM 58 57 36 11
POLYETHYLENE GLYCOL 3350 56 55 37 36
FENTANYL 54 54 S2 38 42
CARBIDOPA-LEVODOPA 54 54 38 47
OXYBUTYNIN CHLORIDE 53 45 40 104
LANTUS 52 52 41 41
ATENOLOL 52 40 41 16
CITALOPRAM HBR 51 39 43 15
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 26, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.